4-hydroxymellein

Metabolite details

Identifier

STSOHAOGZMLWFR-UHFFFAOYSA-N

InChI Key

STSOHAOGZMLWFR-UHFFFAOYSA-N

IUPAC name

4,8-dihydroxy-3-methyl-3,4-dihydro-1H-2-benzopyran-1-one

Preferred name

4-hydroxymellein

INN name

—

Synonym

4,8-dihydroxy-3-methylisochroman-1-one

ChEBI

CHEBI:141335

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Normal_vs_Neural_Tube_Defect
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d
• Control_0d_vs_Treatment_180d